Skip to Main Content

Filter:

Papers from the SFPM 2021

1 Results

Research Article
Cardiac radioablation for ventricular tachycardia: Which approach for incorporating cardiorespiratory motions into the planning target volume?
Physica Medica: European Journal of Medical Physics
Vol. 95p16–24Published online: January 20, 2022
- Julien Bellec
- Louis Rigal
- Aurélien Hervouin
- Raphaël Martins
- Mathieu Lederlin
- Nicolas Jaksic
- and others
Cited in Scopus: 2
Cardiac radioablation (CR) has recently emerged as a therapeutic option to treat cardiac arrhythmias in patients with recurrent ventricular tachycardia (VT) after being treated using the standard workflow, including antiarrhythmic drugs and/or catheter radiofrequency ablation [1]. CR involves the delivery of a single 25 Gy dose to the cardiac substrate identified as the source of abnormal electrical propagation. Both C-arm linear accelerators (linacs) (Elekta and Varian platforms) and the CyberKnife robotic system (Accuray), which are typically implemented for stereotactic body radiotherapy (SBRT), have been considered for CR of VT [2,3].